| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8780848 | Gynecologic Oncology | 2017 | 6 Pages |
Abstract
Our findings suggest that CRT should be the preferred adjuvant treatment strategy for patients with stage IIIC endometrial cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Pratibha S. Binder, Lindsay M. Kuroki, Peinan Zhao, Sarah Cusworth, Laura M. Divine, Andrea R. Hagemann, Carolyn K. McCourt, Premal H. Thaker, Matthew A. Powell, David G. Mutch, L. Stewart Massad,